Form 4 · Filed Feb 26, 2026, 12:00 PM UTC
SUPN/SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank — SVP, Chief Tech. Ops. Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | A | other | 1,875 | $0 | — | 19,083 |
| Feb 25, 2026 | F | other | 977 | $51 | $49,524 | 18,106 |
| Feb 25, 2026 | D | other | 1,875 | $0 | — | 1,875 |
Source: SEC EDGAR raw filing ↗ · Accession 0001804567-26-000006